 |
Interferon beta-1a |
|---|---|
| Trade Name | Rebif |
| Orphan Indication | Patients with secondary progressive multiple sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 1996-03-11 00:00:00 |
| Sponsor | EMD Serono, Inc.;One Technology Place;Rockland, Massachusetts, 02370 |
